| JXSL2400217 | 注射用德曲妥珠单抗 | trastuzumab deruxtecan | Lyophilized | Biological Products(2.2) | Import Drug Application | 2024-11-11 | | | | | view |
| CYSB2400292 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products(3.3) | Supplementary Application | 2024-11-09 | | Anhui Anke Biotechnology (Group) Co Ltd | | | view |
| JXSL2400211 | 注射用德曲妥珠单抗 | trastuzumab deruxtecan | Lyophilized | Biological Products(2.2) | Import Drug Application | 2024-11-01 | | | | | view |
| CYSB2400281 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products(3.3) | Supplementary Application | 2024-10-25 | | QILU Pharmaceutical Co Ltd | | | view |
| CYSB2400265 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products(3.3) | Supplementary Application | 2024-10-09 | | QILU Pharmaceutical Co Ltd | | | view |
| CXSS2400099 | 注射用瑞康曲妥珠单抗 | SHR-A1811 | Lyophilized | Biological Products(1) | New Drug Application | 2024-09-14 | | Suzhou Suncadia Biopharmaceuticals Co Ltd | | | view |
| JYSB2400207 | 注射用恩美曲妥珠单抗 | trastuzumab emtansine | Lyophilized | Biological Products | Supplementary Application | 2024-09-12 | | | | | view |
| JYSB2400206 | 注射用恩美曲妥珠单抗 | trastuzumab emtansine | Lyophilized | Biological Products | Supplementary Application | 2024-09-12 | | | | | view |
| JYSB2400205 | 注射用德曲妥珠单抗 | trastuzumab deruxtecan | Lyophilized | Biological Products | Supplementary Application | 2024-09-11 | | | | | view |
| JYSB2400191 | 注射用恩美曲妥珠单抗 | trastuzumab emtansine | Lyophilized | Biological Products | Supplementary Application | 2024-08-26 | | | | | view |
| JYSB2400190 | 注射用恩美曲妥珠单抗 | trastuzumab emtansine | Lyophilized | Biological Products | Supplementary Application | 2024-08-26 | | | | | view |
| JYSB2400170 | 帕妥珠曲妥珠单抗注射液（皮下注射） | pertuzumab;trastuzumab | Injection | Biological Products | Supplementary Application | 2024-08-03 | | | | | view |
| JYSB2400171 | 帕妥珠曲妥珠单抗注射液（皮下注射） | pertuzumab;trastuzumab | Injection | Biological Products | Supplementary Application | 2024-08-03 | | Roche Pharma (Schweiz) AG | | | view |
| JYSB2400139 | 帕妥珠曲妥珠单抗注射液（皮下注射） | pertuzumab;trastuzumab | Injection | Biological Products | Supplementary Application | 2024-06-28 | | | | | view |
| JYSB2400138 | 帕妥珠曲妥珠单抗注射液（皮下注射） | pertuzumab;trastuzumab | Injection | Biological Products | Supplementary Application | 2024-06-28 | | Roche Pharma (Schweiz) AG | | | view |
| JYSZ2400033 | 注射用恩美曲妥珠单抗 | trastuzumab emtansine | Lyophilized | Biological Products | License Renew | 2024-06-21 | | | | | view |
| JYSZ2400034 | 注射用恩美曲妥珠单抗 | trastuzumab emtansine | Lyophilized | Biological Products | License Renew | 2024-06-21 | | | | | view |
| CYSB2400138 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products | Supplementary Application | 2024-06-01 | | Nanjing Shunxin Pharmaceuticals Co LTDof Chiatai Tianqing Pharmaceutical Group | | | view |
| CYSB2400136 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products(3.3) | Supplementary Application | 2024-05-25 | | Anhui Anke Biotechnology (Group) Co Ltd | | | view |
| JXSB2400050 | 注射用德曲妥珠单抗 | trastuzumab deruxtecan | Lyophilized | Biological Products(2.2) | Supplementary Application | 2024-05-09 | | | | | view |
